MAPT and Alzheimer disease: Sevoflurane, the frequently used anesthetic, could activate the NLRP3/caspase-1/GSDMD cascade, and increase tau phosphorylation and β‐amyloid deposition, hence promoting the progression of Alzheimer’s disease (101).